the canadian american ticlopidine study ( cats ) is a randomised , double-blind , placebo-controlled trial to assess the effect of ticlopidine ( 250 mg twice daily ) in reducing the rate of subsequent occurrence of stroke , myocardial infarction , or vascular death in patients who have had a recent thromboembolic stroke .
C0040207
ticlopidine
C0038454
stroke